You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › December › 09
Pfizer
7 months ago
The deal will help Pfizer beef up and diversify its obesity drug pipeline following its $10 billion acquisition of obesity biotech Metsera last month.
page 1 of 1